PCDH10 exerts tumor-suppressor functions through modulation of EGFR/AKT axis in colorectal cancer
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 499, 290-300
Abstract
No abstract availableKeywords
Funding Information
- Cardinal Tien Hospital
- National Health Research Institutes
This publication has 37 references indexed in Scilit:
- Epithelial-mesenchymal transition - activating transcription factors - multifunctional regulators in cancerWorld Journal of Stem Cells, 2013
- Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancerJournal of Cancer Research and Clinical Oncology, 2012
- Promoter methylation‐mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistanceGenes, Chromosomes and Cancer, 2011
- Proteome mining for novel IgE‐binding proteins from the German cockroach ( Blattella germanica ) and allergen profiling of patientsProteomics, 2010
- Activation of Akt and MAPK pathways enhances the tumorigenicity of CD133+ primary colon cancer cellsCarcinogenesis, 2010
- Field methylation silencing of the protocadherin 10 gene in cervical carcinogenesis as a potential specific diagnostic test from cervical scrapingsCancer Science, 2009
- Involvement of Members of the Cadherin Superfamily in CancerCold Spring Harbor Perspectives in Biology, 2009
- Methylation of Protocadherin 10, a Novel Tumor Suppressor, Is Associated With Poor Prognosis in Patients With Gastric CancerGastroenterology, 2009
- Inhibition of apoptosis by downregulation of hBex1, a novel mechanism, contributes to the chemoresistance of Bcr/Abl+ leukemic cellsCarcinogenesis, 2008
- Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignanciesBritish Journal of Haematology, 2007